November 7, 2025

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A High-Risk, High-Reward Play with 246% Potential Upside

Investors with an appetite for high-risk, high-reward opportunities may find Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) an intriguing prospect. The company, operating within the biotechnology sector, is..

REGENXBIO Inc. (RGNX)

⚠️ No article content returned.

..

Arvinas, Inc. (ARVN) Stock Analysis: Unveiling an 80% Potential Upside in Biotechnology

Arvinas, Inc. (NASDAQ: ARVN), a rising star in the biotechnology sector, offers a compelling narrative for investors seeking opportunities in healthcare innovation. The company, headquartered in..

Enhabit, Inc. (EHAB) Stock Analysis: Evaluating a 21.60% Potential Upside in the Healthcare Sector

Enhabit, Inc. (NASDAQ: EHAB), a key player in the healthcare sector specializing in home health and hospice services, presents a noteworthy case for investors considering the..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Eyeing a 34.5% Upside as Revenue Growth Soars

Theravance Biopharma, Inc. (NASDAQ: TBPH), a promising player in the biotechnology sector, is capturing investor attention with its remarkable revenue growth and a significant potential upside..

Altimmune, Inc. (ALT) Stock Analysis: Exploring a 317% Upside Potential in the Biotech Sector

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, has recently captured the attention of investors with its significant potential upside of 317.37%. Headquartered in Gaithersburg, Maryland,..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: 124% Potential Upside Ignites Investor Interest

Tyra Biosciences, Inc. (NASDAQ: TYRA), a promising clinical-stage biotechnology company situated in the healthcare sector, has captured the attention of investors with an impressive potential upside..

Kura Oncology, Inc. (KURA) Investor Outlook: Analysts Eye a 165% Upside Potential

Kura Oncology, Inc. (KURA) is gaining traction among investors, buoyed by an impressive potential upside of 165.75% as derived from current analyst ratings. This biopharmaceutical company,..

Auna SA (AUNA) Stock Analysis: Exploring a Promising 118.51% Potential Upside

Auna S.A. (AUNA), a significant player in the healthcare sector, is capturing investor attention with its impressive potential upside of 118.51%. As a healthcare service provider..

Cronos Group Inc. (CRON) Stock Analysis: Can This Cannabis Player Overcome a -17.12% Potential Downside?

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, has captured the attention of investors with its diverse product line that includes dried..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Gem with 125% Upside Potential

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a promising player in the biotechnology sector, is making waves with its innovative approach to cancer treatment. With a market capitalization..

Are European equities set for a revival?

Marcel Stötzel, Co-Portfolio Manager of Fidelity European Trust, remains positive on Europe’s investment outlook, citing structural reforms, rising defence spending and potential economic integration as key..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: A 146% Upside Beckons in the Biotech Frontier

For individual investors with a penchant for the biotechnology sector, Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) presents a compelling investment opportunity. With a potential upside of 146.39%..

Orthofix Medical Inc. (OFIX) Investor Outlook: Analyzing a Potential 53.61% Upside in the Healthcare Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its substantial potential..

Avanos Medical, Inc. (AVNS) Stock Analysis: Understanding the Healthcare Innovator’s Future Prospects

Avanos Medical, Inc. (NASDAQ: AVNS), a prominent player in the medical devices industry, is making waves with its innovative healthcare solutions. With a market capitalization of..

Bicycle Therapeutics (BCYC) Stock Analysis: Exploring a 226.85% Upside Potential

For investors keen on the biotechnology sector, Bicycle Therapeutics plc (NASDAQ: BCYC) is currently presenting a fascinating opportunity. This UK-based clinical-stage pharmaceutical company is making waves..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Growth in Healthcare with a 2.46% Upside

As the healthcare sector continues to evolve, InnovAge Holding Corp. (INNV), a key player in the medical care facilities industry, is carving out its niche with..

Amylyx Pharmaceuticals, Inc. (AMLX) Investor Outlook: A 56.95% Potential Upside in Biotech Exploration

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands as a compelling consideration for investors eager to tap into the innovative landscape of biotechnology. With a market capitalization of..

Vir Biotechnology, Inc. (VIR) Investor Outlook: Unpacking a Potential 236% Upside Amidst Challenging Financials

Investors with a taste for high-risk, high-reward opportunities may find Vir Biotechnology, Inc. (NASDAQ: VIR) an intriguing prospect. This clinical-stage biopharmaceutical company, headquartered in San Francisco,..

RxSight, Inc. (RXST) Stock Analysis: Navigating the Healthcare Sector with Innovative Medical Devices

RxSight, Inc. (NASDAQ: RXST) stands at the intersection of cutting-edge technology and medical innovation, offering investors a unique stake in the rapidly evolving healthcare sector. With..

Search

Funds

November 7, 2025

Are European equities set for a revival?

Marcel Stötzel, Co-Portfolio Manager of Fidelity European Trust, remains positive on Europe’s investment outlook, citing structural reforms, rising defence spending and potential economic integration as key drivers...
Search

Funds

November 7, 2025

FTSE 100

Funds